Trial intelligence / Profile preview

Efficacy, Safety and PK of Biostate in Haemophilia A

NCT00879541Phase 2Completed

Sponsor
CSL Limited
Start
Feb 2009
Primary completion
Oct 2010
Modality
Recombinant Proteins and Enzymes
Countries
4
01

Overview

A Phase 2 trial of factor viii + von Willebrand factor in hemophilia A, sponsored by CSL Limited. Started Feb 2009; status: completed.

02

Drugs

factor viii + von Willebrand factor
03

Conditions

hemophilia A

Beyond the preview

Go deeper on NCT00879541.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00879541.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call